A seven-year international study has found aspirin is not beneficial in the primary prevention of cardiovascular disease for those aged over 70.
The ASPREE (ASPirin in Reducing Events in the Elderly) trial found that daily low-dose aspirin (100mg) did not...
A pharmacist-led intervention targeted towards reducing the prevalence of sedative prescription in aged care has reduced antipsychotic prescribing by 13% and that of benzodiazepines by 21%.
The University of Tasmania team led by Prof Greg Peterson and Dr Juanita Westbury...
Endometriosis can result in reduced quality of life and significant burden to the health system.
This evidence summary presents the best available evidence regarding the effectiveness of oral contraceptives for the management of pain associated with endometriosis. For the full...
Thalidomide’s period of use may have been short but its ramifications have lasted decades, both for people who suffer deformities from its effects and how we now regulate medicines.
Like many ‘wonder drugs’ of the 20th century, thalidomide was first...
Fewer than half of all Australians can correctly identify asthma as a chronic disease that doesn’t go away, according to new Asthma Australia research.¹
In the lead up to Asthma Week (1–7 September), Asthma Australia commissioned a survey of 1,012...
With medication issues the top cause of complaints in aged care homes (ACH), we examine attitudes towards the current services, and canvass possibilities for more effective models of care delivery.
In the summer of 2016, Bob Spriggs was given 10...
The TGA has approved a new preventative treatment for migraine, with a new medicine that targets the calcitonin gene-related peptide receptor.
Patients experiencing migraine will soon have a new preventative medicine available that targets the calcitonin gene-related peptide (CGRP) receptor....
Despite an increase in anticonvulsant use for back and neck pain recently - an increase of 535% in the last 10 years - researchers have found such medicines are ineffective for low back or lumbar radicular pain.¹
A systematic meta-analysis...
Scenario
A patient, who identifies as an Aboriginal person, presents to the pharmacy for her monthly prescriptions. Her prescriptions are not annotated as ‘CTG - Closing The Gap PBS Co-payment Measure’. She queries why she has to pay for her...
There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review has concluded.¹
Although short-term PPI therapy side effects such as headache, rash and dizziness and gastrointestinal...
